Ok Biotech Co Ltd Cash Flow-to-Debt Ratio
Ok Biotech Co Ltd cash flow-to-debt ratio. Ok Biotech Co Ltd (4155) has a Cash Flow-to-Debt Ratio of 0.09x as of June 2026, meaning its operating cash flow of NT$126.93 Million could theoretically repay 0% of its total liabilities (NT$1.42 Billion) in one year. Check Ok Biotech Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Ok Biotech Co Ltd (2009–2025)
Cash flow-to-debt ratio of Ok Biotech Co Ltd from 2009 to 2025. Historical debt coverage capacity for Ok Biotech Co Ltd across 17 annual periods. Check Ok Biotech Co Ltd (4155) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Ok Biotech Co Ltd Cash Flow-to-Debt Ratio by Year (2009–2025)
Ok Biotech Co Ltd cash flow-to-debt ratio by year from 2009 to 2025. Year-by-year debt coverage analysis for Ok Biotech Co Ltd. For the full cash flow conversion analysis, see Ok Biotech Co Ltd (4155) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | NT$319.57 Million | NT$1.27 Billion | ▲ +329.7% |
| 2024 | 0.06x | NT$65.90 Million | NT$1.13 Billion | ▲ +1238.7% |
| 2023 | 0.00x | NT$2.93 Million | NT$672.26 Million | ▼ -97.8% |
| 2022 | 0.20x | NT$240.53 Million | NT$1.21 Billion | ▲ +903.5% |
| 2021 | 0.02x | NT$21.90 Million | NT$1.11 Billion | ▼ -89.4% |
| 2020 | 0.19x | NT$147.70 Million | NT$795.91 Million | ▲ +277.3% |
| 2019 | 0.05x | NT$45.18 Million | NT$918.40 Million | ▼ -77.7% |
| 2018 | 0.22x | NT$128.75 Million | NT$582.73 Million | ▲ +45.8% |
| 2017 | 0.15x | NT$102.77 Million | NT$678.07 Million | ▼ -68.0% |
| 2016 | 0.47x | NT$260.72 Million | NT$550.64 Million | ▼ -19.0% |
| 2015 | 0.58x | NT$289.44 Million | NT$495.36 Million | ▲ +1069.0% |
| 2014 | -0.06x | NT$-33.83 Million | NT$561.11 Million | ▼ -158.6% |
| 2013 | 0.10x | NT$87.08 Million | NT$847.00 Million | ▼ -57.7% |
| 2012 | 0.24x | NT$79.17 Million | NT$325.65 Million | ▼ -52.1% |
| 2011 | 0.51x | NT$93.12 Million | NT$183.31 Million | ▲ +346.3% |
| 2010 | -0.21x | NT$-19.52 Million | NT$94.60 Million | ▼ -347.6% |
| 2009 | 0.08x | NT$6.95 Million | NT$83.42 Million | — |